Sirolimus: continuing the evolution of transplant immunosuppression (Q34028674)

30 July 2017

1 reference

title

Sirolimus: continuing the evolution of transplant immunosuppression (English)

1 reference

30 July 2017

1 reference

1 reference

G R Ingle

1

1 reference

30 July 2017

T M Sievers

series ordinal

2

1 reference

30 July 2017

C D Holt

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

Annals of Pharmacotherapy

30 July 2017

1 reference

30 July 2017

34

1 reference

30 July 2017

1044-1055

1 reference

30 July 2017

9

1 reference

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle

30 July 2017

1 reference

Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling.

21 January 2018

1 reference

The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin-associated protein kinase activity and G1 progression

21 January 2018

1 reference

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

PHAS/4E-BPs as regulators of mRNA translation and cell proliferation

21 January 2018

1 reference

Clinically significant drug interactions with cyclosporin. An update

21 January 2018

1 reference

The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin

21 January 2018

1 reference

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

21 January 2018

1 reference

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

21 January 2018

1 reference

Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease

21 January 2018

1 reference

The use of immunomodulators in early rheumatoid arthritis

21 January 2018

1 reference

Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases

21 January 2018

1 reference

Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice

21 January 2018

1 reference

Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.

21 January 2018

1 reference

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

21 January 2018

1 reference

Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients

21 January 2018

1 reference

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.28.727

Identifiers

DOI

10.1345/APH.19380

1 reference

30 July 2017

1 reference